Hyperthermic intraperitoneal chemotherapy (HIPEC), is NOT useful in women with Ovarian Cancer
The role of hyperthermic intraperitoneal chemotherapy (HIPEC) began to be studied more than two decades ago when randomized clinical trials compared surgery plus HIPEC Versus palliative chemotherapy in patients with colorectal cancer.